Origin Therapeutics Holdings Inc. (ORIG.CN) Research

Origin Therapeutics Holdings Inc. functions as an investment firm, predominantly focusing its efforts on the burgeoning psychedelic industry within Canada. Its strategic intent is to finance various stages of development, including scientific research, product conceptualization, manufacturing, quality control, market penetration, and sales of psychedelic substances, alongside any related endeavors. Incorporated in 2020, the company, originally known as 1278700 B.C. Ltd., maintains its main office in Vancouver, Canada.

Market snapshot

Symbol
ORIG.CN
Price
$0.03
Day change
0.00%
Market cap
$1.4M
P/E ratio
-0.60x
52-week range
0.0-0.07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Canada House Cannabis Group Inc. (CHV.CN)
  • Delta 9 Cannabis Inc. (DN.TO)
  • Entourage Health Corp. (ENTG.V)
  • New Leaf Ventures Inc (NLV.CN)
  • Orchid Ventures, Inc. (ORCD.CN)
  • The Hash Corporation (REZN.CN)
  • Silo Wellness Inc. (SILO.CN)
  • TransCanna Holdings Inc. (TCAN.CN)

Open Origin Therapeutics Holdings Inc. (ORIG.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.